SEC Comment Letter for Beyond Air, Inc. (XAIR) (CIK 0001641631) (XAIR) — Jun 15, 2017
Beyond Air, Inc. (XAIR) (CIK 0001641631)
Date: June 15, 2017 · CIK: 0001641631 · Accession: 0000000000-17-021004
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 3030 June 1 5, 2017 Via E -mail Amir Avniel Chief Executive Officer AIT Therapeutics, Inc. 2 Ilan Ramon, Science Park Ness Ziona, 7403635 Israel
Re: AIT Therapeutics, Inc. Registration Statement on Form S-1 Filed June 9, 2017 File No. 333 -218626
Dear M r. Avniel :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Show Raw Text
Mail Stop 3030
June 1 5, 2017
Via E -mail
Amir Avniel
Chief Executive Officer
AIT Therapeutics, Inc.
2 Ilan Ramon, Science Park
Ness Ziona, 7403635 Israel
Re: AIT Therapeutics, Inc.
Registration Statement on Form S-1
Filed June 9, 2017
File No. 333 -218626
Dear M r. Avniel :
This is to advise you that we have not reviewed and will not review your registration
statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Amanda Ravitz
Assistant Director
Office of Electronics and Machinery
cc: Robert L Grossman, Esq.